We are pleased to announce being awarded a CIHR project grant. Our proposal (funded for 4 years; $631,124) is entitled, “Quantitative PSMA Targeted Imaging of Prostate Cancer Patients”. We aim to improve assessment of disease for prostate cancer patients in the context of our ongoing clinical trials involving prostate-specific membrane antigen (PSMA) radioligand therapy (also known as radiopharmaceutical therapy). We will pursue advanced PSMA PET data acquisition (particularly dynamic whole-body imaging), as well as improved image reconstruction and enhancement. Our efforts will also involve automated deep-learning based segmentation of PET images, as well as predictive modeling of prostate cancer using radiomics and machine learning methods.